SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
OSRH

OSR Health, Inc. (OSRH)

United States · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.14+$0.04 (+40.00%)
 
Market cap
$4.94M
Insider Score
Market Cap$4.94M-71.5%
Revenue (ttm)$1.71M
Net Income-$10.22M
EPS-$0.37
Shares Out35.26M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume152,945
Open$0.09
Previous Close$0.10
Day's Range$0.07 - $0.16
52-Week Range$0.05 - $0.90
Betan/a
Analystsnone
Price Target$10.00(+7042.86%)
Earnings Daten/a
+40.00% (1D)
No price history available.

About OSRH

OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. The company was formerly known as OSR Holdings, Inc. and changed its name to OSR Health, Inc. in June 2026. OSR Health, Inc. was incorporated in 2020 and is based in Bellevue, Washington.

Address
10900 NE 4th Street, Bellevue, WA, 98004, United States
Market Cap
5 million
Employees
22
Industrial Classification
Biotechnology
1 Day
+57.30%
5 Days
+40.00%
1 Month
-28.57%
6 Months
-72.55%
1 Year
-71.54%

$OSRH stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in OSRH holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by OSRH's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

OSRH Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New OSRH patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to OSRH from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from OSRH’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.